Galmed Pharmaceuticals Ltd. (GLMD)
0.833
-0.02
(-1.99%)
USD |
NASDAQ |
Jan 09, 16:00
0.8402
+0.01
(+0.86%)
After-Hours: 20:00
Galmed Pharmaceuticals Shareholders Equity (Quarterly): 19.11M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 43.83M |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | 10.49M |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.58M |
| Total Liabilities (Quarterly) | 2.472M |
| Current Ratio | 7.979 |